Besides other emerging molecular targets, prostate specific membrane antigen (PSMA) expression by the neo-vascular endothelium was shown in a large variety of solid tumors including kidney, lung, breast, and pancreas cancer [15, 16]. Here, FOLH1 is linked to pancreatic neoplasm.